Journal profile · CELL & TISSUE ENGINEERING-ENGINEERING, BIOMEDICAL
Tissue Engineering and Regenerative Medicine
ISSN 1738-2696 · eISSN 2212-5469 · Springer Singapore · SOUTH KOREA · 6 issues per year · Founded 2012
Tissue Engineering and Regenerative Medicine: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 5.01; hybrid open access; APC about USD 4,090; median 91 days to acceptance (96 articles, last 24 months); community-reported acceptance: easy; 111 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Tissue Engineering and Regenerative Medicine is published by Springer Singapore and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Mesenchymal stem cell research, Tissue Engineering and Regenerative Medicine and Bone Tissue Engineering Materials, together about 36.7% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Tissue Engineering and Regenerative Medicine is the official journal of the Korean Tissue Engineering and Regenerative Medicine Society and is published on the 1st of January, February, April, June, July, August, October, and December. It has the aim of the publication dedicated to providing information on basic researches related with tissue engineering and regenerative medicine and applications on tissue growth and regeneration as the multidisciplinary journal. It is a peer-reviewed journal that publishes original research papers, reviews, and feature articles in the fields of tissue engineering, medical biomaterials, cell therapy, cell biology, stem cell biology, and regenerative medicine. Organ and tissue target of regeneration include brain and nervous system, cardiovascular system, skeletal muscle, bone and skin, gastrointestinal, genitourinary and other body parts.
From the journal's Aims & Scope
Research area (LetPub): CELL & TISSUE ENGINEERING-ENGINEERING, BIOMEDICAL
Editor-in-chief Inho JoPublisher website
Editorial board by country: 6 in mainland China (about 8%); most named South Korea 53, Mainland China 6, United States 5, Japan 4, Taiwan, China 2 (78 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Mesenchymal stem cell researchMedicine15.8%
- Tissue Engineering and Regenerative MedicineMedicine11%
- Bone Tissue Engineering MaterialsEngineering10%
- Electrospun Nanofibers in Biomedical ApplicationsMaterials Science7.2%
- Periodontal Regeneration and TreatmentsMedicine7.1%
- 3D Printing in Biomedical ResearchEngineering6.5%
- Osteoarthritis Treatment and MechanismsMedicine6.4%
- Wound Healing and TreatmentsMedicine4.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Cell & Tissue Engineering | Zone 3 |
| Minor | Engineering, Biomedical | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Cell & Tissue Engineering | Zone 3 |
| Minor | Engineering, Biomedical | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Cell & Tissue Engineering | Zone 4 |
| Minor | Engineering, Biomedical | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
EI CompendexMEDLINEPubMedEmbaseCASPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 5.01LetPub ·
- Impact factor (publisher) 2025
- 5.1Publisher website ·
- 5-year impact factor (publisher) 2025
- 4.9Publisher website ·
- CiteScore 2026-06
- 8.5LetPub ·
- SJR 2026-06
- 0.97LetPub ·
- SNIP 2026-06
- 0.97LetPub ·
- h-index
- 13LetPub ·
- h-index
- 58OpenAlex ·
- i10-index
- 580OpenAlex ·
- 2-year mean citedness
- 4.25OpenAlex ·
- Self-citation rate
- 5.9%LetPub ·
- Share of gold OA articles
- 20.32%LetPub ·
Volume
- Articles per year
- 84LetPub ·
- Articles per year (publisher)
- 2,019Publisher website ·
- Downloads per year (publisher) 2025
- 316,700Publisher website ·
Articles by year OpenAlex count · 1,374 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 61 | 50 | 19 |
| 2025 | 111 | 83 | 352 |
| 2024 | 70 | 70 | 658 |
| 2023 | 104 | 103 | 1,503 |
| 2022 | 92 | 92 | 1,648 |
| 2021 | 97 | 97 | 2,579 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
91 daysMedian, submission to acceptance · P25–P75 49 days – 128 days
- Acceptance to online
- median 44 days (96 articles)
- Submission to online
- median 137 days
- Sample
- 96 articles with submission and acceptance dates (164 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Submission to first decision
- 18 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,090 / EUR 3,090 / GBP 2,690 | — | — | |
| Publisher website | Yes, amount not published | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteAuthorship, License & copyright, Open access, Peer review
- Authorship
Authors must confirm to society they will pay Publication Fee (Review and Handling Charge) and APC (OA Fee) if accepted Model summary
Please choose one of the publishing options and send to the society(kterms.edit@gmail.com) your confirmation that you will pay the following Publication Fee (Review and Handling Charge) and Article Processing Charges (APC, OA Fee) if your article is accepted.
Source ↗Publisher website ·- License & copyright Copyright Transfer statement
Please find the form at the Link below Copyright Transfer statement (Download pdf, 34 kB)
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in Tissue Engineering and Regenerative Medicine, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Peer review
Two review tracks: Regular track and FAST track Model summary
There are 2 review tracks which are the Regular track and the FAST track.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer Singapore
- Country or region
- SOUTH KOREA
- Language
- English
- Frequency
- 6 issues per year
- Founded
- 2012
- ISSN
- 1738-2696
- Electronic ISSN
- 2212-5469
- Latest issue on the website
- Volume 23, Issue 6 (August 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Tissue Engineering and Regenerative Medicine
What CAS zone is Tissue Engineering and Regenerative Medicine in?
In the 2025 upgraded edition of the CAS Journal Ranking, Tissue Engineering and Regenerative Medicine is in Zone 3 of Medicine, and in Zone 3 of the minor category Cell & Tissue Engineering / Engineering, Biomedical. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Tissue Engineering and Regenerative Medicine?
The latest impact factor listed by LetPub is 5.01; CiteScore 8.5, h-index 58.
How long does peer review take at Tissue Engineering and Regenerative Medicine?
Based on the dates recorded on 96 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 91 days (interquartile range 49–128 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Tissue Engineering and Regenerative Medicine based?
Of the 78 board members whose country the journal's board page names, 6 (about 8%) are in mainland China; the countries named most often are South Korea (53), Mainland China (6) and United States (5). Counted from the institutions listed on the board page; for reference only.
Which databases index Tissue Engineering and Regenerative Medicine?
According to LetPub and DOAJ records, Tissue Engineering and Regenerative Medicine is indexed in SCIE and Scopus. The journal's website also lists EI Compendex, MEDLINE, PubMed, Embase and CAS; that list has not been checked against each database.
Is Tissue Engineering and Regenerative Medicine open access, and what is the APC?
Tissue Engineering and Regenerative Medicine is a hybrid journal. For open-access publication: APC about USD 4,090.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .